Healthcare -
Biotechnology - NASDAQ - US
$ 6.47
-0.919 %
$ 277 M
Market Cap
-11.55
P/E
DMAC - TOTAL CURRENT LIABILITIES
Total Current Liabilities DMAC - DiaMedica Therapeutics Inc.
2.79 M
LAST VALUE
35.21%
2 YEAR CAGR
16.54%
5 YEAR CAGR
6.21%
10 YEAR CAGR